98591-51-6

Usage

Uses

Used in Organic Synthesis:
2-BROMO-4-(4-BROMO-PHENYL)-THIAZOLE is utilized as a building block in organic synthesis for the creation of complex organic molecules. Its unique structure allows for versatile chemical reactions, making it a valuable component in the synthesis of a wide range of compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-BROMO-4-(4-BROMO-PHENYL)-THIAZOLE is employed as a key intermediate in the development of new drugs. Its potential biological and pharmacological properties, such as antimicrobial and antifungal activities, make it a promising candidate for the treatment of various diseases and conditions.
Used in Agrochemical Development:
2-BROMO-4-(4-BROMO-PHENYL)-THIAZOLE is also considered in the agrochemical sector for the development of new pesticides and other agricultural chemicals. Its unique chemical properties and reactivity offer the potential to create effective and novel agrochemicals that can address various agricultural challenges.
Used in Antimicrobial and Antifungal Applications:
2-BROMO-4-(4-BROMO-PHENYL)-THIAZOLE has been studied for its antimicrobial and antifungal properties, making it a potential candidate for use in applications that require the inhibition of microbial growth. This can be particularly useful in medical, pharmaceutical, and industrial settings where controlling microbial contamination is crucial.

InChI:InChI=1/C9H5Br2NS/c10-7-3-1-6(2-4-7)8-5-13-9(11)12-8/h1-5H

Upstream product

• 99-73-0 para-bromophenacyl bromide 
• 65679-14-3 1-(4-bromophenyl)-2-thiocyanatoethanone 

Downstream Products

• 42056-77-9 4-(4-bromophenyl)-N-phenyl-1,3-thiazol-2-amine 
• 1007130-50-8 (2R)-2-{[4-(4-bromophenyl)-1,3-thiazol-2-yl]amino}propan-1-ol 
• 1007315-23-2 N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]ethane-1,2-diamine 
• 1007130-51-9 (2R)-2-{[4-(4-bromophenyl)-1,3-thiazol-2-yl]amino}pentan-1-ol 
• 1007583-00-7 (2S)-2-{[4-(4-bromophenyl)-1,3-thiazol-2-yl]amino}propan-1-ol 
• 1007583-01-8 2-{[4-(4-bromophenyl)-1,3-thiazol-2-yl]amino}-2-methylpropan-1-ol 
• 1007583-02-9 (2S)-2-{[4-(4-bromophenyl)-1,3-thiazol-2-yl]amino}butan-1-ol 
• 1007583-03-0 (2R)-2-{[4-(4-bromophenyl)-1,3-thiazol-2-yl]amino}butan-1-ol 
• 1007583-39-2 (R)-3-benzyloxy-2-[4-(4-bromo-phenyl)-thiazol-2-ylamino]-propan-1-ol 
• 1007583-04-1 (2S)-2-{[4-(4-bromophenyl)-5-chloro-1,3-thiazol-2-yl]amino}butan-1-ol 

Relevant academic research and scientific papers

Oxazolidone derivatives as PR modulators

Compounds of the following structure are described: wherein R1, R2, R5, R6, V, X, Y, Z and Q are described herein, or a pharmaceutically acceptable salt, tautomer, metabolite or prodrug thereof. These compounds are useful for treating a variety of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus.

Tricyclic oxazolidone derivatives useful as PR modulators

Compounds of the following structure are described: wherein R1-R6, R16, m, V, W, X, Y, and Q are described herein, or a pharmaceutically acceptable salt, tautomer, metabolite or prodrug thereof. These compounds are use

Imidazolidin-2-one derivatives useful as PR modulators

Compounds of the following structure are described: wherein R1-R6, R10, m, V, X, Y, Z and Q are described herein, or a pharmaceutically acceptable salt, tautomer, metabolite or prodrug thereof. These compounds are useful f

Oxazolidine derivatives as PR modulators

Compounds of the following structure are described: wherein R1-R6, m, V, W, X, Y, Z and Q are described herein, or a pharmaceutically acceptable salt, tautomer, metabolite or prodrug thereof. These compounds are useful for treating a

Oxazinan-2-one derivatives useful as PR modulators

Compounds of the following structure are described: wherein R1-R6, m, V, X, Y, Z and Q are described herein, or a pharmaceutically acceptable salt, tautomer, metabolite or prodrug thereof. These compounds are useful for treating a va

Pyrrolidine and related derivatives useful as PR modulators

Compounds of the following structure are described: wherein R1-R6, R11, R12, m, V, X, Y, Z and Q are described herein, or a pharmaceutically acceptable salt, tautomer, metabolite or prodrug thereof. These compou